{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:51:22Z","timestamp":1790844682695,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cognitive impairments in patients with myotonic dystrophy type 1 (DM1) have often been described, however, there are only few studies differentiating between partial performance disorders and mental retardation in common. This study focused on the evaluation of reading performance and the frequency of dyslexia in adult DM1 patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a prospective cohort study including genetically confirmed adult DM1 patients registered in the DM registry of Germany or the internal database of the Friedrich-Baur-Institute, Munich, Germany. For the assessment of the patients\u2019 reading and spelling performance, we used the standardized and validated test \u201aSalzburger Lese- und Rechtschreibtest\u2018 (SLRT II). The \u201aCFT-20 R Grundintelligenztest Skala 2\u2018 in revised (\"R\") version (CFT 20-R), determining the intelligence level, was appropriate to differentiate between dyslexia and general mental retardation. The diagnosis of dyslexia, the combined reading and spelling disorder, was based on the guidelines for diagnosis and therapy of children and adolescents with dyslexia 2015 (S3-guideline) providing (1) the criterion of the divergence from age level and (2) the criterion of IQ-divergence.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fifty-seven DM1 patients participated in our study. Evaluating the reading performance, 16 patients fulfilled the divergence criteria of the age level and 2 patients the IQ-divergence criteria. In total, the diagnosis of a reading disorder was given in 18 DM1 patients (31.6 %). In 11 out of these 18 patients with a reading disorder, a relevant impairment of spelling performance was observed with at least three spelling errors. As there are no normative values for adults in spelling performance, we assume a combined reading disorder and dyslexia, in those 11 DM1 patients (19.3 %). Regarding the separate analyses of the test procedures, in the SLRT II the performance was below average in 40.4 % of all patients for \u2018word reading\u2019 and in 61.4 % of all patients for \u2018pseudoword reading\u2019. There was a significant positive correlation between the CTG expansion size and a reading disorder (p=0.027). The average IQ of 17 examined DM1 patients was in the lower normal range (86.1 \u00b1 19.1). 54.5 % of patients with reading disorder had a normal IQ.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The calculated prevalence of dyslexia in the DM1 study cohort was 19.3 % and thus considerably increased compared to the normal German population. As dyslexia is not equivalent to a general cognitive impairment, it is important not to miss dyslexic features in cognitive inconspicuous DM1 patients. Case-by-case one should consider a differential diagnostic approach, as individualized therapies can be offered to support dyslexic patients in their performance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-020-10161-6","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T18:03:54Z","timestamp":1598465034000},"page":"484-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dyslexia and cognitive impairment in adult patients with myotonic dystrophy type 1: a clinical prospective analysis"],"prefix":"10.1007","volume":"268","author":[{"given":"K.","family":"Gutschmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wenninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Montagnese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2757-8131","authenticated-orcid":false,"given":"B.","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"issue":"Pt 11","key":"10161_CR1","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/brain\/awp236","volume":"132","author":"FL Norwood","year":"2009","unstructured":"Norwood FL et al (2009) Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 132(Pt 11):3175\u20133186","journal-title":"Brain"},{"issue":"2","key":"10161_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.nmd.2016.12.005","volume":"27","author":"C Lindberg","year":"2017","unstructured":"Lindberg C, Bjerkne F (2017) Prevalence of myotonic dystrophy type 1 in adults in western Sweden. Neuromuscul Disord 27(2):159\u2013162","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10161_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","volume":"68","author":"JD Brook","year":"1992","unstructured":"Brook JD et al (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 68(4):799\u2013808","journal-title":"Cell"},{"issue":"5049","key":"10161_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.1546325","volume":"255","author":"M Mahadevan","year":"1992","unstructured":"Mahadevan M et al (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3\u2019 untranslated region of the gene. Science 255(5049):1253\u20131255","journal-title":"Science"},{"issue":"5531","key":"10161_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"CL Liquori","year":"2001","unstructured":"Liquori CL et al (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293(5531):864\u2013867","journal-title":"Science"},{"issue":"1","key":"10161_CR6","first-page":"10","volume":"51","author":"PS Harper","year":"1992","unstructured":"Harper PS et al (1992) Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet 51(1):10\u201316","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10161_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1212\/CPJ.0000000000000531","volume":"8","author":"T Ashizawa","year":"2018","unstructured":"Ashizawa T et al (2018) Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract 8(6):507\u2013520","journal-title":"Neurol Clin Pract"},{"issue":"4","key":"10161_CR8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbadis.2014.05.019","volume":"1852","author":"G Meola","year":"2015","unstructured":"Meola G, Cardani R (2015) Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms. Biochim Biophys Acta 1852(4):594\u2013606","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10161_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1469-8749.2012.04379.x","volume":"54","author":"M Douniol","year":"2012","unstructured":"Douniol M et al (2012) Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1. Dev Med Child Neurol 54(10):905\u2013911","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"10161_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1212\/WNL.0b013e318260cbe6","volume":"79","author":"C Heatwole","year":"2012","unstructured":"Heatwole C et al (2012) Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology 79(4):348\u2013357","journal-title":"Neurology"},{"issue":"6","key":"10161_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ajmg.b.30698","volume":"147B","author":"AB Ekstrom","year":"2008","unstructured":"Ekstrom AB et al (2008) Autism spectrum conditions in myotonic dystrophy type 1: a study on 57 individuals with congenital and childhood forms. Am J Med Genet B Neuropsychiatr Genet 147B(6):918\u2013926","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"3","key":"10161_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0006-3223(99)00016-5","volume":"46","author":"GI Perini","year":"1999","unstructured":"Perini GI et al (1999) Cognitive impairment and (CTG)n expansion in myotonic dystrophy patients. Biol Psychiat 46(3):425\u2013431","journal-title":"Biol Psychiat"},{"issue":"4","key":"10161_CR13","first-page":"239","volume":"38","author":"S Peric","year":"2019","unstructured":"Peric S et al (2019) Fatigue in myotonic dystrophy type 1: a seven-year prospective study. Acta Myol 38(4):239\u2013244","journal-title":"Acta Myol"},{"issue":"3","key":"10161_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejpn.2007.07.014","volume":"12","author":"B Echenne","year":"2008","unstructured":"Echenne B et al (2008) Myotonic dystrophy type I in childhood Long-term evolution in patients surviving the neonatal period. Eur J Paediatr Neurol 12(3):210\u2013223","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"10161_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jneuroling.2006.03.007","volume":"19","author":"D Cohen","year":"2006","unstructured":"Cohen D et al (2006) Reading and spelling impairments in children and adolescents with infantile myotonic dystrophy. J Neurolinguist 19(6):455\u2013465","journal-title":"J Neurolinguist"},{"issue":"14","key":"10161_CR16","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/02699050500283509","volume":"19","author":"JA Macniven","year":"2005","unstructured":"Macniven JA et al (2005) A 5-year follow-up study of an atypical case of myotonic dystrophy. Brain Inj 19(14):1213\u20131221","journal-title":"Brain Inj"},{"issue":"41","key":"10161_CR17","first-page":"718","volume":"107","author":"G Schulte-Korne","year":"2010","unstructured":"Schulte-Korne G (2010) The prevention, diagnosis, and treatment of dyslexia. Deutsches Arzteblatt international 107(41):718\u2013726 (quiz 27)","journal-title":"Deutsches Arzteblatt international"},{"issue":"8","key":"10161_CR18","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/jama.1990.03450080084036","volume":"264","author":"SE Shaywitz","year":"1990","unstructured":"Shaywitz SE et al (1990) Prevalence of reading disability in boys and girls. Results of the Connecticut Longitudinal Study. JAMA 264(8):998\u20131002","journal-title":"JAMA"},{"key":"10161_CR19","unstructured":"Bundesverband Legasthenie und Dyskalkulie e.V. (2018) Ratgeber zum Thema Legasthenie\u2014Erkennen und Verstehen, vol 112. Auflage"},{"key":"10161_CR20","volume-title":"Lese-und Rechtschreibtest (SLRT-II). Weiterentwicklung des Salzburger Lese-Rechtschreibtests (SLRT)","author":"K Moll","year":"2014","unstructured":"Moll K, Landerl K (2014) Lese-und Rechtschreibtest (SLRT-II). Weiterentwicklung des Salzburger Lese-Rechtschreibtests (SLRT). Verlag Hans Huber, Bern"},{"key":"10161_CR21","unstructured":"Leitlinie, Diagnostik und Behandlung von Kindern und Jugendlichen mit Lese-und\/oder Rechtschreibst\u00f6rung (2015) Deutsche Gesellschaft f\u00fcr Kinder und Jugendpsychiatrie, Psychosomatik und Psychotherapie (DGKJP)"},{"issue":"14","key":"10161_CR22","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1212\/WNL.0b013e3181d8c35f","volume":"74","author":"YG Weber","year":"2010","unstructured":"Weber YG et al (2010) Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology 74(14):1108\u20131117","journal-title":"Neurology"},{"issue":"6","key":"10161_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.nmd.2012.01.003","volume":"22","author":"DT Franc","year":"2012","unstructured":"Franc DT et al (2012) Cerebral and muscle MRI abnormalities in myotonic dystrophy. Neuromuscul Disord 22(6):483\u2013491","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10161_CR24","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1468-1331.2008.02217.x","volume":"15","author":"S Winblad","year":"2008","unstructured":"Winblad S et al (2008) Cerebrospinal fluid tau and amyloid beta42 protein in patients with myotonic dystrophy type 1. Eur J Neurol 15(9):947\u2013952","journal-title":"Eur J Neurol"},{"issue":"9","key":"10161_CR25","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/ene.13062","volume":"23","author":"S Winblad","year":"2016","unstructured":"Winblad S et al (2016) Cognition in myotonic dystrophy type 1: a 5-year follow-up study. Eur J Neurol 23(9):1471\u20131476","journal-title":"Eur J Neurol"},{"key":"10161_CR26","unstructured":"Wei\u00df RH (2006) CFT 20-R mit WS\/ZF-R Grundintelligenztest Skala 2"},{"issue":"15","key":"10161_CR27","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1001\/jama.1993.03500150072029","volume":"269","author":"JB Redman","year":"1993","unstructured":"Redman JB et al (1993) Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA 269(15):1960\u20131965","journal-title":"JAMA"},{"key":"10161_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13023-014-0186-5","volume":"9","author":"S Jean","year":"2014","unstructured":"Jean S et al (2014) Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1). Orphanet J Rare Dis 9:186","journal-title":"Orphanet J Rare Dis"},{"key":"10161_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1744-9081-2-16","volume":"2","author":"S Winblad","year":"2006","unstructured":"Winblad S, Lindberg C, Hansen S (2006) Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1). Behav Brain Funct 2:16","journal-title":"Behav Brain Funct"},{"issue":"3","key":"10161_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1017\/S0033291709990602","volume":"40","author":"A Sistiaga","year":"2010","unstructured":"Sistiaga A et al (2010) Cognitive\/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1. Psychol Med 40(3):487\u2013495","journal-title":"Psychol Med"},{"issue":"10","key":"10161_CR31","doi-asserted-by":"publisher","first-page":"e995","DOI":"10.1212\/WNL.0000000000008056","volume":"93","author":"SA Cumming","year":"2019","unstructured":"Cumming SA et al (2019) Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort. Neurology 93(10):e995\u2013e1009","journal-title":"Neurology"},{"issue":"16","key":"10161_CR32","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1001\/jama.291.16.2007","volume":"291","author":"M Rutter","year":"2004","unstructured":"Rutter M et al (2004) Sex differences in developmental reading disability: new findings from 4 epidemiological studies. JAMA 291(16):2007\u20132012","journal-title":"JAMA"},{"issue":"1","key":"10161_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/thg.2020.7","volume":"23","author":"C Doust","year":"2020","unstructured":"Doust C et al. (2020) The association of dyslexia and developmental speech and language disorder candidate genes with reading and language abilities in adults. Twin Res Hum Genet 23(1):1\u201310","journal-title":"Twin Res Hum Genet"},{"issue":"6","key":"10161_CR34","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/1096-8628(20001204)96:6<888::AID-AJMG42>3.0.CO;2-7","volume":"96","author":"J Steyaert","year":"2000","unstructured":"Steyaert J et al (2000) Behavioral phenotype in childhood type of dystrophia myotonica. Am J Med Genet 96(6):888\u2013889","journal-title":"Am J Med Genet"},{"issue":"2","key":"10161_CR35","doi-asserted-by":"publisher","first-page":"e0148264","DOI":"10.1371\/journal.pone.0148264","volume":"11","author":"C Dogan","year":"2016","unstructured":"Dogan C et al (2016) Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study. PLoS ONE 11(2):e0148264","journal-title":"PLoS ONE"},{"issue":"2","key":"10161_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/ene.12237","volume":"21","author":"S Peric","year":"2014","unstructured":"Peric S et al (2014) Cerebrospinal fluid biomarkers of neurodegeneration in patients with juvenile and classic myotonic dystrophy type 1. Eur J Neurol 21(2):231\u2013237","journal-title":"Eur J Neurol"},{"issue":"3","key":"10161_CR37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1212\/WNL.47.3.711","volume":"47","author":"P Vermersch","year":"1996","unstructured":"Vermersch P et al (1996) Specific tau variants in the brains of patients with myotonic dystrophy. Neurology 47(3):711\u2013717","journal-title":"Neurology"},{"issue":"Pt 12","key":"10161_CR38","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1093\/brain\/awr299","volume":"134","author":"M Minnerop","year":"2011","unstructured":"Minnerop M et al (2011) The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain 134(Pt 12):3530\u20133546","journal-title":"Brain"},{"issue":"8","key":"10161_CR39","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1007\/s00415-010-5498-3","volume":"257","author":"V Romeo","year":"2010","unstructured":"Romeo V et al (2010) Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2. J Neurol 257(8):1246","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10161-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10161-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10161-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T23:33:03Z","timestamp":1629934383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10161-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10161"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10161-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors report no disclosures regarding this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"The study was approved by the Ethics Committee of the Ludwig Maximilian University of Munich, Germany (IRB vote no. 38-14) and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All patients gave an informed consent for their participation in the study and publication of the results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}